80. Resistance to thyroid hormone Disease details / Clinical trials / Drug dev / DR info


Clinical trial : 1 Drugs : 4 - (DrugBank : 3) / Drug target genes : 3 - Drug target pathways : 4

Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countries)
Hypothyroidism QOL questionnaire
   Memorial Sloan Kettering Cancer Center
      2021   Phase 1   NCT04868045   United States
Levothyroxine
   Memorial Sloan Kettering Cancer Center
      2021   Phase 1   NCT04868045   United States
Thyrotropin releasing hormone
   Memorial Sloan Kettering Cancer Center
      2021   Phase 1   NCT04868045   United States
TRH
   Memorial Sloan Kettering Cancer Center
      2021   Phase 1   NCT04868045   United States